Reminder: OOS Survey - Participation possible until 8 April
Recommendation

20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
As reported in our last newsletter, the ECA Analytical Quality Control Group (AQCG) is currently collecting input via a short survey to support the revision and update of its guidance on Out-of-Specification (OOS) investigations.
If you have not yet participated, participation is still possible until 8 April 2026.
All responses will be evaluated in an aggregated and fully anonymized manner. None of the questions are mandatory, and participants may skip any questions they prefer not to answer. At the end of the survey, respondents are also invited to propose additional topics or questions that AQCG should consider in future guidance documents.
The revision of the guideline is planned immediately after the survey closes, and a summary report of the survey results will be prepared and made available to all members.
Thank you for your valuable time and support.
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation

